Contrast echocardiography in Canada: Canadian Cardiovascular Society/Canadian Society of Echocardiography position paper

Canadian Journal of Cardiology

Volumn 23, Issue 5, 2007, Pages 351-356

  Honos, George ^a   Amyot, Robert ^b   Choy, Jonathan ^c   Leong Poi, Howard ^d   Schnell, Greg ^e   Yu, Eric ^f  

^a MCGILL UNIVERSITY   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e Foothills General Hospital   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Contrast; Echocardiography; Imaging; Perfusion

Indexed keywords

ADENOSINE; AI 700; ALBUNEX; BY 963; CARDIOSPHERE; DIPYRIDAMOLE; DOBUTAMINE; ECHO CONTRAST MEDIUM; FS 069; NC 100100; PERFLEXANE; PERFLUOROPENTANE; PERFLUTREN; SHU 508; SODIUM CHLORIDE; SONOVUE; UNCLASSIFIED DRUG; CONTRAST MEDIUM;

AORTA DISSECTION; ARTICLE; CANADA; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART RUPTURE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE QUALITY; INTERRATER RELIABILITY; INTRACARDIAC THROMBOSIS; MEDICAL SOCIETY; MICROBUBBLE; PERCUTANEOUS CORONARY INTERVENTION; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; IMAGE ENHANCEMENT; LUNG CIRCULATION; METHODOLOGY; PATHOPHYSIOLOGY; STANDARD;

CANADA; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; HUMANS; IMAGE ENHANCEMENT; PULMONARY CIRCULATION; VENTRICULAR FUNCTION, LEFT;

EID: 34249649689     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(07)70767-5     Document Type: Article

References (55)

1. Hoffmann R, von Bardeleben S, Ten Cate F, et al. Assessment of systolic left ventricular function: A multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J 2005;26:607-16.
2. Lindner JR, Dent JM, Moos SP, Jayaweera AR, Kaul S. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex. Am J Cardiol 1997;79:1657-62.
3. de Laat LE, Galema TW, Krenning BJ, Roelandt JR. Diagnosis of non-compaction cardiomyopathy with contrast echocardiography. Int J Cardiol 2004;94:127-8.
4. von der Recke G, Schmidt H, Illien S, Luderitz B, Omran H. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion. J Am Soc Echocardiogr 2002;15:1256-61.
5. von Bibra H, Sutherland G, Becher H, Neudert J, Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. The Levovist Cardiac Working Group. J Am Coll Cardiol 1995;25:500-8.
6. Rainbird AJ, Mulvagh SL, Oh JK, et al. Contrast dobutamine stress echocardiography: Clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 2001;14378-85.
7. Lindner JR, Villanueva FS, Dent JM, Wei K, Sklenar J, Kaul S. Assessment of resting perfusion with myocardial contrast echocardiography: Theoretical and practical considerations. Am Heart J 2000;139:231-40.
8. Wei K, Ragosta M, Thorpe J, Coggins M, Moos S, Kaul S. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation 2001;103:2560-5.
9. Rinkevich D, Kaul S, Wang XQ, et al. Regional left ventricular perfusion and function in patients presenting to the emergency department with chest pain and no ST-segment elevation. Eur Heart J 2005;26:1606-11.
10. Tsutsui JM, Xie F, O'Leary EL, et al. Diagnostic accuracy and prognostic value of dobutamine stress myocardial contrast echocardiography in patients with suspected acute coronary syndromes. Echocardiography 2005;22:487-95.
11. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-66.
12. Feinstein SB, Shah PM, Bing RJ, et al. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol 1984;4:595-600.
13. Shapiro JR, Reisner SA, Lichtenberg GS, Meltzer RS. Intravenous contrast echocardiography with use of sonicated albumin in humans: Systolic disappearance of left ventricular contrast after transpulmonary transmission. J Am Coll Cardiol 1990;6:1603-7.
14. Schlief R, Staks T, Mahler M, et al. Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent. Echocardiography 1990;7:61-4.
15. Feinstein SB, Cheirif J, Ten Cate FJ, et al. Safety and efficacy of a new transpulmonary contrast agent: Initial multicenter clinical results. J Am Coll Cardiol 1990;16:316-24.
16. Porter TR, Xie F. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases. J Am Coll Cardiol 1995;25:509-15.
17. Burns PN, Powers JE, Fritzsch T. Harmonic imaging: A new imaging and Doppler method for contrast enhanced ultrasound. Radiology 1992;185:142.
18. Porter TR, Xie F, Kricsfeld D, Armbruster RW. Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. J Am Coll Cardiol 1996;27:1497-501.
19. Becher H, PN Burns. Contrast agents for echocardiography: Principles and instrumentation. In: Becher H, Burns PN, eds. Handbook of Contrast Echocardiography. Left Ventricular Function and Myocardial Perfusion. Berlin: Springer Verlag, 2000:2-42.
20. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
21. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302.
22. Serruys PW, Simoons ML, Suryapranata H, et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 1986;7:729-42.
23. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
24. Boucher CA, Bingham JB, Osbakken MD, et al. Early changes in left ventricular size and function after correction of left ventricular volume overload. Am J Cardiol 1981;47:991-1004.
25. Porter TR, Xie F, Kricsfeld A, Chiou A, Dabestani A. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994;23:1440-3.
26. Crouse LJ, Cheirif J, Hanly DE, et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the Phase III Albunex Multicenter Trial. J Am Coll Cardiol 1993;22:1494-500.
27. Dias BF, Yu EH, Sloggett CE, Iwanochko RM, Rakowski H, Siu SC. Contrast-enhanced quantitation of left ventricular ejection fraction: What is the best method? J Am Soc Echocardiogr 2001;14:1183-90.
28. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: Comparison with cine magnetic resonance imaging. J Am Coll Cardiol 1998;32:1426-32.
29. Thomson HL, Basmadjian AJ, Rainbird AJ, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: A prospective, randomly assigned, blinded study. J Am Coll Cardiol 2001;38:867-75.
30. Yu EH, Sloggett CE, Iwanochko RM, Rakowski H, Siu SC. Feasibility and accuracy of left ventricular volumes and ejection fraction determination by fundamental, tissue harmonic, and intravenous contrast imaging in difficult-to-image patients. J Am Soc Echocardiogr 2000;13:216-24.
31. Yu EH, Skyba DM, Sloggett CE, et al. Determination of left ventricular ejection fraction using intravenous contrast and a semiautomated border detection algorithm. J Am Soc Echocardiogr 2003;16:22-8.
32. Spencer KT, Bednarz J, Mor-Avi V, Decara J, Lang RM. Automated endocardial border detection and evaluation of left ventricular function from contrast-enhanced images using modified acoustic quantification. J Am Soc Echocardiogr 2002;15:777-81.
33. Hoffmann R, Lethen H, Marwick T, et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 1996;27:330-6.
34. Dolan MS, Riad K, El-Shafei A, et al. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 2001;142:908-15.
35. Mathias W Jr, Arruda AL, Andrade JL, Filho OC, Porter TR. Endocardial border delineation during dobutamine infusion using contrast echocardiography. Echocardiography 2002;19:109-14.
36. Ikonomidis I, Holmes E, Narbuvold H, Bolstad B, Muan B, Nihoyannopoulos P. Assessment of left ventricular wall motion and delineation of the endocardial border after intravenous injection of Infoson during dobutamine stress echocardiography. Coron Artery Dis 1998;9:567-76.
37. Uehara H, Yamamoto T, Hirano Y, et al. [Contrast agent improves diagnostic value of dobutamine stress echocardiography]. J Cardiol 2001;37:135-41.
38. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.
39. Lepper W, Hoffmann R, Kamp O, et al. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of angiography] in patients with acute myocardial infarction. Circulation 2000;101:2368-74. (Erratum in 2000;102:482).
40. Swinburn JM, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol 2001;38:19-25.
41. Tong KL, Belcik T, Kalvaitis S, et al. Intact microvascular integrity predicts improvement in left ventricular function after revascularization in patients with chronic coronary artery disease. J Am Coll Cardiol 2003;41(Suppl A):4330. (Abst)
42. Coggins MP, Sklenar J, Le DE, Wei K, Lindner JR, Kaul S. Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation 2001;104:2471-7.
43. Elhendy A, O'Leary EL, Xie F, McGrain AC, Anderson JR, Porter TR. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 2004;44:2185-91.
44. Jeetley P, Hickman M, Kamp O, et al. Myocardial contrast echocardiography for the detection of coronary artery stenosis: A prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol 2006;47:141-5.
45. Wei K, Crouse L, Weiss J, et al. Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 Multicenter Phase 2 Trial results). Am J Cardiol 2003;91:1293-8.
46. Tong KL, Kaul S, Wang XQ, et al. Myocardial contrast echocardiography versus Thrombolysis In Myocardial Infarction score in patients presenting to the emergency department with chest pain and a nondiagnostic electrocardiogram. J Am Coll Cardiol 2005;46:920-7.
47. Tsutsui JM, Elhendy A, Xie F, O'Leary EL, McGrain AC, Porter TR. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 2005;45:1235-42.
48. Basic D, Siu SC, Skyba DM, et al. Prognostic value of myocardial perfusion contrast echocardiography in patients with suggested or known ischemic heart disease. J Am Soc Echocardiogr 2006;19:1203-10.
49. Kaul S, Senior R, Firschke C, et al. Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST segment elevation: A multicenter study. Am Heart J 2004;148:129-36.
50. Marwick TH, Brunken R, Meland N, et al. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: Comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 Investigators. J Am Coll Cardiol 1998;32:1260-9.
51. Tardif JC, Dore A, Chan KL, et al. Economic impact of contrast stress echocardiography on the diagnosis and initial treatment of patients with suspected coronary artery disease. J Am Soc Echocardiogr 2002;15:1335-45.
52. Castello R, Bella JN, Rovner A, Swan J, Smith J, Shaw L. Efficacy and time-efficiency of a "sonographer-driven" contrast echocardiography protocol in a high-volume echocardiography laboratory. Am Heart J 2003;145:535-41.
53. Christiansen JP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 2002;105:1764-7.
54. Leong-Poi H, Christiansen JP, Heppner P, et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 2005;111:3248-54.
55. Bekeredjian R, Chen S, Frenkel PA, Grayburn PA, Shohet RV. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003;108:1022-6.